Catalyst Pharmaceuticals (CPRX) announced the appointment of Daniel Curran, MD, to its Board of Directors. Since March 2024, Curran has served as Managing Partner of Mountainfield Venture Partners
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CPRX: